Author

T. Chalopin

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Preprint Sep 2026

Universal scaling of fluctuations and correlations across the superfluid transition

The critical behavior of a system near a continuous phase transition is commonly characterized by power laws and a set of universal critical exponents. Yet universality at phase transitions has even more fundamental manifestations. It dictates that all observables follow universal scaling functions, which may extend be...

Paul Paquiez, Géraud Dupuy, Maxime Allemand et al. · 0 citations

Open access Sep 2026

BCMA Targeted Therapies and Their Impact on Outcomes in Relapsed or Refractory Multiple Myeloma: Results From the French EMMY Cohort.

OBJECTIVES B-cell maturation antigen (BCMA)-targeted therapies have recently transformed the management of relapsed or refractory multiple myeloma (RRMM). This study aimed to evaluate their implementation and real-world impact within EMMY, a French longitudinal cohort. METHODS Patients initiating a fourth or later li...

T. Cazaubiel, O. Decaux, A. Perrot et al. · European Journal of Haematol... · 0 citations

Sep 2026

[Evolving strategies for relapsed multiple myeloma: Toward personalized treatment in 2026].

Multiple myeloma (MM) is a malignant plasma cell disorder whose prognosis has significantly improved with the introduction of proteasome inhibitors, immunomodulatory drugs, anti-CD38 monoclonal antibodies, and more recently BCMA-targeted immunotherapies. In 2026, MM is considered a chronic disease requiring individuali...

P. Debureaux, T. Cazaubiel, T. Chalopin et al. · Bulletin du Cancer · 0 citations